Premium
P3‐018: An Evaluation of the Safety of Nelotanserin, A Highly Potent and Selective 5‐HT2A Inverse Agonist That is Being Developed as a Treatment for Visual Hallucinations and REM Behavior Disorder in Lewy Body Dementia
Author(s) -
Wen Warren,
Ramaswamy Shankar,
Piscitelli Stephen C.,
Cicero Sherri,
Lynch Shau Yu,
Friedhoff Lawrence
Publication year - 2016
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2016.06.1675
Subject(s) - dementia with lewy bodies , monoaminergic , rem sleep behavior disorder , dementia , medicine , rapid eye movement sleep , agonist , disease , psychology , audiology , neuroscience , psychiatry , parkinson's disease , serotonin , electroencephalography , receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom